<DOC>
<DOCNO>
EP-0010668
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
C07H-19/23 <main>A61K-31/70</main> A61P-37/00 A61P-37/06 C07H-19/052 A61K-31/185 C07H-19/00 A61K-31/425 A61K-31/33 A61K-31/70 A61K-31/195 A61K-31/7042 A61P-43/00 A61K-31/7052 
</IPC-CLASSIFICATIONS>
<TITLE>
3-deazaadenosine and pharmaceutical compositions containing it.
</TITLE>
<APPLICANT>
wellcome found gb<sep>the wellcome foundation limited<sep>the wellcome foundation limitedunicorn house 160 euston road p.o. box 129london nw1 2bpgb<sep>the wellcome foundation limited<sep>
</APPLICANT>
<INVENTOR>
wolberg gerald<sep>zimmerman thomas paul<sep>wolberg, gerald<sep>zimmerman, thomas paul<sep>wolberg, gerald1109 troon courtcary, north carolina 27511us<sep>zimmerman, thomas paul1415 brunson courtcary, north carolina 27511us<sep>wolberg, gerald  <sep>zimmerman, thomas paul<sep>wolberg, gerald1109 troon courtcary, north carolina 27511us<sep>zimmerman, thomas paul1415 brunson courtcary, north carolina 27511us<sep>
</INVENTOR>
<ABSTRACT>
adenosine derivatives for inhibition of immune  response are disclosed.  adenosine derivatives of  formula (i)    wherein r¹ is amino or lower alkyl amino;   r² is hydrogen or an aliphatic carboxylic acid  residue; and   r³ is hydrogen, aliphatic carboxylic acid residue  or a phosphoric acid residue,   are useful as inhibitora of immune response.  the activity  is potentiated by derivatives of homocysteine and homo­ cystine.  particularty useful is 3-deaza-adenosine both  alone and in combination with -homocysteine thio­ lacetone, pharmaceutical formulations of compounds of  formula (i) alone and with potentiators are provided.  
</ABSTRACT>
</TEXT>
</DOC>
